Sarcomeric α-actinins and their role in human muscle disease

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Blanchard A, Ohanian V, Critchley D: The structure and function of α-actinin. J. Muscle Res. Cell. Motil.10,280–289 (1989).
  Medline CASGoogle Scholar
• 2  North KN, Yang N, Wattanasirichaigoon D et al.: A common nonsense mutation results in α-actinin-3 deficiency in the general population. Nat. Genet.21,353–354 (1999).▪▪ First report of a common mutation in α-actinin-3 ( ACTN3) in the general population.
  Medline CASGoogle Scholar
• 3  Noegel A, Witke W, Schleicher M: Calcium-sensitive non-muscle α-actinin contains EF-hand structures and highly conserved regions. FEBS Lett.221,391–396 (1987).
  Medline CASGoogle Scholar
• 4  Fyrberg E, Kelly M, Ball E et al.: Molecular genetics of Drosophila α-actinin: mutant alleles disrupt Z disc integrity and muscle insertions. J. Cell Biol.110,1999–2011 (1990).
  Medline CASGoogle Scholar
• 5  Barstead RJ, Kleiman L, Waterston RH: Cloning, sequencing, and mapping of an α-actinin gene from the nematode Caenorhabditis elegans. Cell Motil. Cytoskeleton20,69–78 (1991).
  Medline CASGoogle Scholar
• 6  Arimura C, Suzuki T, Yanagisawa M et al.: Primary structure of chicken skeletal muscle and fibroblast α-actinins deduced from cDNA sequences. Eur. J. Biochem.177,649–655 (1988).
  Medline CASGoogle Scholar
• 7  Beggs AH, Byers TJ, Knoll JH et al.: Cloning and characterization of two human skeletal muscle α-actinin genes located on chromosomes 1 and 11. J. Biol. Chem.267,9281–9288 (1992).
  Medline CASGoogle Scholar
• 8  MacArthur DG, North KN: A gene for speed? The evolution and function of α-actinin-3. Bioessays26,786–795 (2004).▪▪ Comprehensive review of the evolution and role of α-actinin-3 in humans.
  Medline CASGoogle Scholar
• 9  Honda K, Yamada T, Endo R et al.: Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J. Cell Biol.140,1383–1393 (1998).
  Medline CASGoogle Scholar
• 10  Krakhmaleva IN, Shishkin SS, Shakhovskaia NI et al.: NP-detecting DNA technologies: solving problems of applied biochemistry. Prikl Biokhim. Mikrobiol.41,303–307 (2005).
  Medline CASGoogle Scholar
• 11  Mills M, Yang N, Weinberger R et al.: Differential expression of the actin-binding proteins, α-actinin-2 and -3, in different species: implications for the evolution of functional redundancy. Hum. Mol. Genet.10,1335–1346 (2001).▪ Detailed analysis of the expression of sarcomeric α-actinins.
  Medline CASGoogle Scholar
• 12  Southby J, Gooding C, Smith CW: Polypyrimidine tract binding protein functions as a repressor to regulate alternative splicing of α-actinin mutally exclusive exons. Mol. Cell Biol.19,2699–2711 (1999).
  Medline CASGoogle Scholar
• 13  Mukhina S, Wang YL, Murata-Hori M: α-actinin is required for tightly regulated remodeling of the actin cortical network during cytokinesis. Dev. Cell13,554–565 (2007).
  Medline CASGoogle Scholar
• 14  Otey CA, Carpen O: α-actinin revisited: a fresh look at an old player. Cell Motil. Cytoskeleton58,104–111 (2004).
  Medline CASGoogle Scholar
• 15  Ehler E, Gautel M: The sarcomere and sarcomerogenesis. Adv. Exp. Med. Biol.642,1–14 (2008).
  Medline CASGoogle Scholar
• 16  North KN, Beggs AH: Deficiency of a skeletal muscle isoform of α-actinin (α-actinin-3) in merosin-positive congenital muscular dystrophy. Neuromuscul. Disord.6,229–235 (1996).▪ First report of a mutation in ACTN3 not associated with a disease phenotype.
  Medline CASGoogle Scholar
• 17  Sjoblom B, Salmazo A, Djinovic-Carugo K: α-actinin structure and regulation. Cell. Mol. Life Sci.65,2688–2701 (2008).
  Medline CASGoogle Scholar
• 18  Kuhlman PA, Ellis J, Critchley DR et al.: The kinetics of the interaction between the actin-binding domain of α-actinin and F-actin. FEBS Lett.339,297–301 (1994).
  Medline CASGoogle Scholar
• 19  Salmikangas P, Mykkanen OM, Gronholm M et al.: Myotilin, a novel sarcomeric protein with two Ig-like domains, is encoded by a candidate gene for limb-girdle muscular dystrophy. Hum. Mol. Genet.8,1329–1336 (1999).
  Medline CASGoogle Scholar
• 20  Ohtsuka H, Yajima H, Maruyama K et al.: Binding of the N-terminal 63 kDa portion of connectin/titin to α-actinin as revealed by the yeast two-hybrid system. FEBS Lett.401,65–67 (1997).
  Medline CASGoogle Scholar
• 21  Nave R, Furst DO, Weber K: Interaction of α-actinin and nebulin in vitro. Support for the existence of a fourth filament system in skeletal muscle. FEBS Lett.269,163–166 (1990).
  Medline CASGoogle Scholar
• 22  Hance JE, Fu SY, Watkins SC et al.: α-actinin-2 is a new component of the dystrophin-glycoprotein complex. Arch. Biochem. Biophys.365,216–222 (1999).
  Medline CASGoogle Scholar
• 23  Otey CA, Pavalko FM, Burridge K: An interaction between α-actinin and the β1 integrin subunit in vitro. J. Cell Biol.111,721–729 (1990).
  Medline CASGoogle Scholar
• 24  Ervasti JM, Campbell KP: Membrane organization of the dystrophin–glycoprotein complex. Cell66,1121–1131 (1991).
  Medline CASGoogle Scholar
• 25  Watkins SC, Cullen MJ, Hoffman EP et al.: Plasma membrane cytoskeleton of muscle: a fine structural analysis. Microsc Res Tech48,131–141 (2000).
  Medline CASGoogle Scholar
• 26  Endo T, Masaki T: Differential expression and distribution of chicken skeletal- and smooth-muscle-type α-actinins during myogenesis in culture. J. Cell Biol.99,2322–2332 (1984).
  Medline CASGoogle Scholar
• 27  Goffart S, Franko A, Clemen CS et al.: α-actinin 4 and BAT1 interaction with the cytochrome c promoter upon skeletal muscle differentiation. Curr. Genet.49,125–135 (2006).
  Medline CASGoogle Scholar
• 28  Argov Z, Yarom R: Rimmed vacuole myopathy sparing the quadriceps. A unique disorder in Iranian Jews. J. Neurol. Sci.64,33–43 (1984).
  Medline CASGoogle Scholar
• 29  Eisenberg I, Avidan N, Potikha T et al.: The UDP- N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat. Genet.29,83–87 (2001).
  Medline CASGoogle Scholar
• 30  Amsili S, Zer H, Hinderlich S et al.: UDP- N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) binds to α-actinin 1: novel pathways in skeletal muscle? PLoS ONE3,E2477 (2008).
  MedlineGoogle Scholar
• 31  Malicdan MC, Noguchi S, Hayashi YK et al.: Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model. Nat. Med.15,690–695 (2009).
  Medline CASGoogle Scholar
• 32  Keppler OT, Hinderlich S, Langner J et al.: UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation. Science284,1372–1376 (1999).
  Medline CASGoogle Scholar
• 33  Kaplan JM, Kim SH, North KN et al.: Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis. Nat. Genet.24,251–256 (2000).
  Medline CASGoogle Scholar
• 34  Weins A, Kenlan P, Herbert S et al.: Mutational and biological analysis of α-actinin-4 in focal segmental glomerulosclerosis. J. Am. Soc. Nephrol.16,3694–3701 (2005).
  Medline CASGoogle Scholar
• 35  Kos CH, Le TC, Sinha S et al.: Mice deficient in α-actinin-4 have severe glomerular disease. J. Clin. Invest.111,1683–1690 (2003).
  Medline CASGoogle Scholar
• 36  Yao J, Le TC, Kos CH et al.: α-actinin-4-mediated FSGS: an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein. PLoS Biol2,E167 (2004).
  MedlineGoogle Scholar
• 37  Menez J, Le Maux Chansac B, Dorothee G et al.: Mutant α-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinoma. Oncogene23,2630–2639 (2004).
  Medline CASGoogle Scholar
• 38  Dec GW, Fuster V: Idiopathic dilated cardiomyopathy. N. Engl. J. Med.331,1564–1575 (1994).
  Medline CASGoogle Scholar
• 39  Kamisago M, Sharma SD, DePalma SR et al.: Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N. Engl. J. Med.343,1688–1696 (2000).▪ Mutation in ACTN2 resulting in cardiomyopathy.
  Medline CASGoogle Scholar
• 40  Chang AN, Potter JD: Sarcomeric protein mutations in dilated cardiomyopathy. Heart Fail. Rev.10,225–235 (2005).
  Medline CASGoogle Scholar
• 41  Mohapatra B, Jimenez S, Lin JH et al.: Mutations in the muscle LIM protein and α-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol. Genet. Metab.80,207–215 (2003).
  Medline CASGoogle Scholar
• 42  Sadler I, Crawford AW, Michelsen JW et al.: Zyxin and cCRP: two interactive LIM domain proteins associated with the cytoskeleton. J. Cell Biol.119,1573–1587 (1992).
  Medline CASGoogle Scholar
• 43  Nix DA, Beckerle MC: Nuclear-cytoplasmic shuttling of the focal contact protein, zyxin: a potential mechanism for communication between sites of cell adhesion and the nucleus. J. Cell Biol.138,1139–1147 (1997).
  Medline CASGoogle Scholar
• 44  Dubreuil RR: Structure and evolution of the actin crosslinking proteins. Bioessays13,219–226 (1991).
  Medline CASGoogle Scholar
• 45  Roulier EM, Fyrberg C, Fyrberg E: Perturbations of Drosophila α-actinin cause muscle paralysis, weakness, and atrophy but do not confer obvious nonmuscle phenotypes. J. Cell Biol.116,911–922 (1992).
  Medline CASGoogle Scholar
• 46  Macarthur DG, Seto JT, Chan S et al.: An Actn3 knockout mouse provides mechanistic insights into the association between α-actinin-3 deficiency and human athletic performance. Hum. Mol. Genet.17(8),1076–1086 (2008).
  Medline CASGoogle Scholar
• 47  MacArthur DG, Seto JT, Raftery JM et al.: Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans. Nat. Genet.39,1261–1265 (2007).▪  ACTN3-knockout mouse phenotype and evolutionary data.
  Medline CASGoogle Scholar
• 48  Nowak KJ, Wattanasirichaigoon D, Goebel HH et al.: Mutations in the skeletal muscle α-actin gene in patients with actin myopathy and nemaline myopathy. Nat. Genet.23,208–212 (1999).
  Medline CASGoogle Scholar
• 49  Jennekens FG, Roord JJ, Veldman H et al.: Congenital nemaline myopathy. I. Defective organization of α-actinin is restricted to muscle. Muscle Nerve6,61–68 (1983).
  Medline CASGoogle Scholar
• 50  Ryan MM, Ilkovski B, Strickland CD et al.: Clinical course correlates poorly with muscle pathology in nemaline myopathy. Neurology60,665–673 (2003).
  Medline CASGoogle Scholar
• 51  Ryan MM, Schnell C, Strickland CD et al.: Nemaline myopathy: a clinical study of 143 cases. Ann. Neurol.50,312–320 (2001).
  Medline CASGoogle Scholar
• 52  North K: Congenital myopathies. In: Myology. Engel A, Franzini-Armstrong C (Eds). McGraw Hill, NY, USA, 1473–1534 (2004).
  Google Scholar
• 53  Domazetovska A, Ilkovski B, Cooper ST et al.: Mechanisms underlying intranuclear rod formation. Brain130,3275–3284 (2007).
  MedlineGoogle Scholar
• 54  Lin Z, Hijikata T, Zhang Z et al.: Dispensability of the actin-binding site and spectrin repeats for targeting sarcomeric α-actinin into maturing Z bands in vivo: implications for in vitro binding studies. Dev. Biol.199,291–308 (1998).
  Medline CASGoogle Scholar
• 55  Schultheiss T, Choi J, Lin ZX et al.: A sarcomeric α-actinin truncated at the carboxyl end induces the breakdown of stress fibers in PtK2 cells and the formation of nemaline-like bodies and breakdown of myofibrils in myotubes. Proc. Natl Acad. Sci. USA89,9282–9286 (1992).
  Medline CASGoogle Scholar
• 56  Zhang ZQ, Bish LT, Holtzer H et al.: Sarcomeric-α-actinin defective in vinculin-binding causes Z-line expansion and nemaline-like body formation in cultured chick myotubes. Exp. Cell Res.315,748–759 (2009).▪ Possible role of defective α-actinin binding in nemaline myopathy pathogenesis.
  Medline CASGoogle Scholar
• 57  Goebel HH, Warlo I: Nemaline myopathy with intranuclear rods – intranuclear rod myopathy. Neuromuscul. Disord.7,13–19 (1997).
  Medline CASGoogle Scholar
• 58  Hutchinson DO, Charlton A, Laing NG et al.: Autosomal dominant nemaline myopathy with intranuclear rods due to mutation of the skeletal muscle ACTA1 gene: clinical and pathological variability within a kindred. Neuromuscul. Disord.16,113–121 (2006).
  MedlineGoogle Scholar
• 59  Agrawal PB, Strickland CD, Midgett C et al.: Heterogeneity of nemaline myopathy cases with skeletal muscle a-actin gene mutations. Ann. Neurol.56,86–96 (2004).
  Medline CASGoogle Scholar
• 60  Sparrow JC, Nowak KJ, Durling HJ et al.: Muscle disease caused by mutations in the skeletal muscle α-actin gene ( ACTA1). Neuromuscul. Disord.13,519–531 (2003).
  MedlineGoogle Scholar
• 61  North KN, Laing NG: Skeletal muscle α-actin diseases. Adv. Exp. Med. Biol.642,15–27 (2008).
  Medline CASGoogle Scholar
• 62  Young KG, Kothary R: Spectrin repeat proteins in the nucleus. Bioessays27,144–152 (2005).
  Medline CASGoogle Scholar
• 63  Domazetovska A, Ilkovski B, Kumar V et al.: Intranuclear rod myopathy: molecular pathogenesis and mechanisms of weakness. Ann. Neurol.62,597–608 (2007).
  Medline CASGoogle Scholar
• 64  Goldfarb LG, Park KY, Cervenakova L et al.: Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat. Genet.19,402–403 (1998).
  Medline CASGoogle Scholar
• 65  Vicart P, Caron A, Guicheney P et al.: A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy. Nat. Genet.20,92–95 (1998).
  Medline CASGoogle Scholar
• 66  Vorgerd M, van der Ven PF, Bruchertseifer V et al.: A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. Am. J. Hum. Genet.77,297–304 (2005).
  Medline CASGoogle Scholar
• 67  Quinzii CM, Vu TH, Min KC et al.: X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1. Am. J. Hum. Genet.82,208–213 (2008).
  Medline CASGoogle Scholar
• 68  Selcen D, Engel AG: Mutations in myotilin cause myofibrillar myopathy. Neurology62,1363–1371 (2004).
  Medline CASGoogle Scholar
• 69  Selcen D, Engel AG: Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann. Neurol.57,269–276 (2005).
  Medline CASGoogle Scholar
• 70  Selcen D, Muntoni F, Burton BK et al.: Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann. Neurol.65,83–89 (2009).
  Medline CASGoogle Scholar
• 71  Claeys KG, van der Ven PF, Behin A et al.: Differential involvement of sarcomeric proteins in myofibrillar myopathies: a morphological and immunohistochemical study. Acta Neuropathol117,293–307 (2009).▪ Recent review on the role of sarcomeric proteins in myofibrillar myopathies.
  Medline CASGoogle Scholar
• 72  Selcen D: Myofibrillar myopathies. Curr. Opin. Neurol.21,585–589 (2008).
  Medline CASGoogle Scholar
• 73  Nakano S, Engel AG, Akiguchi I et al.: Myofibrillar myopathy. III. Abnormal expression of cyclin-dependent kinases and nuclear proteins. J. Neuropathol. Exp. Neurol.56,850–856 (1997).
  Medline CASGoogle Scholar
• 74  Reimann J, Kunz WS, Vielhaber S et al.: Mitochondrial dysfunction in myofibrillar myopathy. Neuropathol. Appl. Neurobiol.29,45–51 (2003).
  MedlineGoogle Scholar
• 75  Schroder R, Goudeau B, Simon MC et al.: On noxious desmin: functional effects of a novel heterozygous desmin insertion mutation on the extrasarcomeric desmin cytoskeleton and mitochondria. Hum. Mol. Genet.12,657–669 (2003).
  Medline CASGoogle Scholar
• 76  Milner DJ, Mavroidis M, Weisleder N et al.: Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function. J. Cell Biol.150,1283–1298 (2000).
  Medline CASGoogle Scholar
• 77  Selcen D, Ohno K, Engel AG: Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients. Brain127,439–451 (2004).
  MedlineGoogle Scholar
• 78  Claeys KG, Fardeau M, Schroder R et al.: Electron microscopy in myofibrillar myopathies reveals clues to the mutated gene. Neuromuscul. Disord.18,656–666 (2008).
  Medline CASGoogle Scholar
• 79  Selcen D, Engel AG: Myofibrillar myopathy. In: Myology. Engel A, Franzini-Armstrong C (Eds). McGraw Hill, NY, USA 1187–1202 (2004).
  Google Scholar
• 80  Hauser MA, Horrigan SK, Salmikangas P et al.: Myotilin is mutated in limb girdle muscular dystrophy 1A. Hum. Mol. Genet.9,2141–2147 (2000).
  Medline CASGoogle Scholar
• 81  Salmikangas P, van der Ven PF, Lalowski M et al.: Myotilin, the limb-girdle muscular dystrophy 1A (LGMD1A) protein, cross-links actin filaments and controls sarcomere assembly. Hum. Mol. Genet.12,189–203 (2003).▪ Sarcomeric α-actinin associated with myotilin.
  Medline CASGoogle Scholar
• 82  Yang N, MacArthur DG, Gulbin JP et al.: ACTN3 genotype is associated with human elite athletic performance. Am. J. Hum. Genet.73,627–631 (2003).▪▪ First report of α-actinin-3-null polymorphism (R577X) influencing muscle performance in elite Australian athletes.
  Medline CASGoogle Scholar
• 83  Druzhevskaya AM, Ahmetov, II, Astratenkova IV et al.: Association of the ACTN3 R577X polymorphism with power athlete status in Russians. Eur. J. Appl. Physiol.103,631–634 (2008).
  Medline CASGoogle Scholar
• 84  Niemi AK, Majamaa K: Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes. Eur. J. Hum. Genet.13,965–969 (2005).
  Medline CASGoogle Scholar
• 85  Papadimitriou ID, Papadopoulos C, Kouvatsi A et al.: The ACTN3 gene in elite Greek track and field athletes. Int. J. Sports Med.29,352–355 (2008).
  Medline CASGoogle Scholar
• 86  Roth SM, Walsh S, Liu D et al.: The ACTN3 R577X nonsense allele is under-represented in elite-level strength athletes. Eur. J. Hum. Genet.16,391–394 (2008).
  Medline CASGoogle Scholar
• 87  Santiago C, Gonzalez-Freire M, Serratosa L et al.: ACTN3 genotype in professional soccer players. Br. J. Sports Med.42,71–73 (2008).
  Medline CASGoogle Scholar
• 88  Eynon N, Duarte JA, Oliveira J et al.: ACTN3 R577X polymorphism and Israeli top-level athletes. Int. J. Sports Med. (2009).
  Google Scholar
• 89  Clarkson PM, Hoffman EP, Zambraski E et al.: ACTN3 and MLCK genotype associations with exertional muscle damage. J. Appl. Physiol.99,564–569 (2005).
  Medline CASGoogle Scholar
• 90  Moran CN, Yang N, Bailey ME et al.: Association analysis of the ACTN3 R577X polymorphism and complex quantitative body composition and performance phenotypes in adolescent Greeks. Eur. J. Hum. Genet.15,88–93 (2007).
  Medline CASGoogle Scholar
• 91  Clarkson PM, Devaney JM, Gordish-Dressman H et al.: ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J. Appl. Physiol.99,154–163 (2005).
  Medline CASGoogle Scholar
• 92  Delmonico MJ, Kostek MC, Doldo NA et al.: α-actinin-3 ( ACTN3) R577X polymorphism influences knee extensor peak power response to strength training in older men and women. J. Gerontol. A Biol. Sci. Med. Sci.62,206–212 (2007).
  MedlineGoogle Scholar
• 93  Vincent B, De Bock K, Ramaekers M et al.: The ACTN3 (R577X) genotype is associated with fiber type distribution. Physiol. Genomics32(1),58–63 (2007).
  Medline CASGoogle Scholar
• 94  MacArthur DG, North KN: ACTN3: a genetic influence on muscle function and athletic performance. Exerc. Sport Sci. Rev.35,30–34 (2007).
  MedlineGoogle Scholar
• 95  Chan S, Seto JT, MacArthur DG et al.: A gene for speed: contractile properties of isolated whole EDL muscle from an α-actinin-3 knockout mouse. Am. J. Physiol. Cell Physiol.295,C897–C904 (2008).
  Medline CASGoogle Scholar
• 96  Lucia A, Gomez-Gallego F, Santiago C et al.: The 577X allele of the ACTN3 gene is associated with improved exercise capacity in women with McArdle’s disease. Neuromuscul. Disord.17,603–610 (2007).▪ First report of ACTN3 genotype influencing disease severity in the metabolic disorder McArdle’s disease.
  MedlineGoogle Scholar
• 97  Tsujino S, Shanske S, DiMauro S: Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle’s disease). N. Engl. J. Med.329,241–245 (1993).
  Medline CASGoogle Scholar
• 98  Li HH, Kedar V, Zhang C et al.: Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J. Clin. Invest.114,1058–1071 (2004).
  Medline CASGoogle Scholar
• 99  Papa I, Astier C, Kwiatek O et al.: α actinin-CapZ, an anchoring complex for thin filaments in Z-line. J. Muscle Res. Cell. Motil.20,187–197 (1999).
  Medline CASGoogle Scholar
• 100  Rakus D, Pasek M, Krotkiewski H et al.: Interaction between muscle aldolase and muscle fructose 1,6-bisphosphatase results in the substrate channeling. Biochemistry43,14948–14957 (2004).
  Medline CASGoogle Scholar
• 101  Gizak A, Rakus D, Dzugaj A: Immunohistochemical localization of human fructose-1,6-bisphosphatase in subcellular structures of myocytes. Histol. Histopathol.18,135–142 (2003).
  Medline CASGoogle Scholar
• 102  Chowrashi P, Mittal B, Sanger JM et al.: Amorphin is phosphorylase; phosphorylase is an α-actinin-binding protein. Cell Motil. Cytoskeleton53,125–135 (2002).
  Medline CASGoogle Scholar
• 103  Lane RD, Hegazy MG, Reimann EM: Subcellular localization of glycogen synthase with monoclonal antibodies. Biochem. Int.18,961–970 (1989).
  Medline CASGoogle Scholar
• 104  Shibasaki F, Fukami K, Fukui Y et al.: Phosphatidylinositol 3-kinase binds to α-actinin through the p85 subunit. Biochem. J.302(Pt 2),551–557 (1994).
  Medline CASGoogle Scholar
• 105  Pashmforoush M, Pomies P, Peterson KL et al.: Adult mice deficient in actinin-associated LIM-domain protein reveal a developmental pathway for right ventricular cardiomyopathy. Nat. Med.7,591–597 (2001).
  Medline CASGoogle Scholar
• 106  Au Y, Atkinson RA, Guerrini R et al.: Solution structure of ZASP PDZ domain; implications for sarcomere ultrastructure and enigma family redundancy. Structure12,611–622 (2004).
  Medline CASGoogle Scholar
• 107  Faulkner G, Pallavicini A, Formentin E et al.: ZASP: a new Z-band alternatively spliced PDZ-motif protein. J. Cell Biol.146,465–475 (1999).
  Medline CASGoogle Scholar
• 108  Frey N, Olson EN: Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins. J. Biol. Chem.277,13998–14004 (2002).
  Medline CASGoogle Scholar
• 109  Frey N, Richardson JA, Olson EN: Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc. Natl Acad. Sci. USA97,14632–14637 (2000).
  Medline CASGoogle Scholar
• 110  Sadeghi A, Doyle AD, Johnson BD: Regulation of the cardiac L-type Ca²⁺ channel by the actin-binding proteins α-actinin and dystrophin. Am. J. Physiol. Cell Physiol.282,C1502–C1511 (2002).
  Medline CASGoogle Scholar
• 111  Maruoka ND, Steele DF, Au BP et al.: α-actinin-2 couples to cardiac Kv1.5 channels, regulating current density and channel localization in HEK cells. FEBS Lett.473,188–194 (2000).
  Medline CASGoogle Scholar
• 112  Cukovic D, Lu GW, Wible B et al.: A discrete amino terminal domain of Kv1.5 and Kv1.4 potassium channels interacts with the spectrin repeats of α-actinin-2. FEBS Lett.498,87–92 (2001).
  Medline CASGoogle Scholar
• 113  Wyszynski M, Lin J, Rao A et al.: Competitive binding of α-actinin and calmodulin to the NMDA receptor. Nature385,439–442 (1997).
  Medline CASGoogle Scholar
• 114  Freeman JL, Pitcher JA, Li X et al.: α-actinin is a potent regulator of G protein-coupled receptor kinase activity and substrate specificity in vitro. FEBS Lett.473,280–284 (2000).
  Medline CASGoogle Scholar
• 115  Park JB, Kim JH, Kim Y et al.: Cardiac phospholipase D2 localizes to sarcolemmal membranes and is inhibited by α-actinin in an ADP-ribosylation factor-reversible manner. J. Biol. Chem.275,21295–21301 (2000).
  Medline CASGoogle Scholar
• 116  Mukai H, Toshimori M, Shibata H et al.: Interaction of PKN with α-actinin. J. Biol. Chem.272,4740–6 (1997).
  Medline CASGoogle Scholar
• 117  Arber S, Halder G, Caroni P: Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell79,221–231 (1994).
  Medline CASGoogle Scholar
• 118  Crawford AW, Michelsen JW, Beckerle MC: An interaction between zyxin and α-actinin. J. Cell Biol.116,1381–1393 (1992).
  Medline CASGoogle Scholar